Skip to content

Covid-19 during pregnancy - Histopathological lesions of the placenta

Covid-19 during pregnancy - Histopathological lesions of the placenta

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032000
Enrollment
50
Registered
2023-06-05
Start date
2022-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: Covid-19 infection during pregnancy and labor = patients with via PCR proven SARS-CoV-2 infection during pregnancy or under labor with delivery 37 0/7 - 41 6/7 weeks of gestation. Group 2: co

Sponsors

Klinikum im Friedrichshain
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: inclusion criteria Covid-19 patient group: a) Covid-19 infection during pregnancy inclusion criteria control group: a) gestational age 37 0/7 - 41 6/7 weeks of gestation b) uncomplicated pregnancy

Exclusion criteria

Exclusion criteria: exclusion criteria Covid-19 patient group: a) minor of age b) not capable of consent exclusion criteria control group: a) minor of age b) not capable of consent c) gestational or pre-existing diabetes mellitus d) placental insufficiency e) gestosis f) triple I

Design outcomes

Primary

MeasureTime frame
histoathological lesions of placental specimen concerning inflammation and hypercoagulopathy (pervillous fibrin deposit, infarction, intervillous thrombi, intervillositis)

Secondary

MeasureTime frame
• number of vaginal delivery, vaginal operative delivery, cesarean section • number of symptomatic Covid-19 infections • number of severe Covid-19 infections • number of placental insufficiency (defined as intrauterine growth restriction, oligohydramnios, abnormal fetal doppler ultrasound) • number of late miscarriages • number of intrauterine fetal death • number of premature abruption of the placenta • number of occurrence of preeclampsia secondary criteria: • maternal age • maternal comorbidities • gestational age at time of delivery • gestational age at the time of the Covid-19 illness • type of Covid-19 symptoms

Countries

Germany

Contacts

Public ContactJulia Kummer

Klinikum im Friedrichshain

julia.kummer@vivantes.de+491606155063

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026